Toshihiko Tashima

Yokohama, 2220035, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Membrane Protein Clustering as a Key Determinant of Endocytosis: Natural Mechanisms, Nonintentional Transporter Internalization, and Engineered Multivalent Nanocarriers.

Membrane Protein Clustering as a Key Determinant of Endocytosis: Natural Mechanisms, Nonintentional Transporter Internalization, and Engineered Multivalent Nanocarriers.

Journal: Journal of medicinal chemistry

Published: July 20, 2026

Synthesis and preliminary biological evaluation of resveratrol-like carbostyril derivatives as sirtuin 1 modulators and cyclooxygenase inhibitors.

Synthesis and preliminary biological evaluation of resveratrol-like carbostyril derivatives as sirtuin 1 modulators and cyclooxygenase inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: May 11, 2026

Emerging cellular uptake mechanisms of bRo5 PROTACs.

Emerging cellular uptake mechanisms of bRo5 PROTACs.

Journal: RSC medicinal chemistry

Published: March 27, 2026

Synthesis and biological evaluation of structurally L-shaped carbostyril derivatives with integrated side chains as cyclooxygenase inhibitors.

Synthesis and biological evaluation of structurally L-shaped carbostyril derivatives with integrated side chains as cyclooxygenase inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: January 26, 2026

Effective Non-Invasive Delivery of Epigenetic Drugs Using Functionalized Accessory Unit Conjugates.

Effective Non-Invasive Delivery of Epigenetic Drugs Using Functionalized Accessory Unit Conjugates.

Journal: Pharmaceutics

Published: December 24, 2025

Nanoparticle-Mediated Targeted Drug Delivery Systems.

Nanoparticle-Mediated Targeted Drug Delivery Systems.

Journal: Pharmaceutics

Published: October 28, 2025

Nanoparticle-Based Targeted Drug Delivery Methods for Heart-Specific Distribution in Cardiovascular Therapy.

Nanoparticle-Based Targeted Drug Delivery Methods for Heart-Specific Distribution in Cardiovascular Therapy.

Journal: Pharmaceutics

Published: September 17, 2025

Non-Invasive Delivery of CRISPR/Cas9 Ribonucleoproteins (Cas9 RNPs) into Cells via Nanoparticles for Membrane Transport.

Non-Invasive Delivery of CRISPR/Cas9 Ribonucleoproteins (Cas9 RNPs) into Cells via Nanoparticles for Membrane Transport.

Journal: Pharmaceutics

Published: January 09, 2025

Non-Invasive Device-Mediated Drug Delivery to the Brain across the Blood-Brain Barrier.

Non-Invasive Device-Mediated Drug Delivery to the Brain across the Blood-Brain Barrier.

Journal: Pharmaceutics

Published: February 22, 2024

Mesenchymal Stem Cell (MSC)-Based Drug Delivery into the Brain across the Blood-Brain Barrier.

Mesenchymal Stem Cell (MSC)-Based Drug Delivery into the Brain across the Blood-Brain Barrier.

Journal: Pharmaceutics

Published: January 17, 2024

Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier.

Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier.

Journal: Antibodies (Basel, Switzerland)

Published: April 22, 2023

Delivery of Drugs into Cancer Cells Using Antibody-Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect.

Delivery of Drugs into Cancer Cells Using Antibody-Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect.

Journal: Antibodies (Basel, Switzerland)

Published: October 28, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026